Aclaris Therapeutics (GB:0H8T)
LSE:0H8T
Holding GB:0H8T?
Track your performance easily

Aclaris Therapeutics (0H8T) Financial Statements

0 Followers

Aclaris Therapeutics Financial Overview

Aclaris Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aclaris Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 4.35M$ 2.77M$ 2.40M$ 17.57M$ 9.28M
Gross Profit$ 3.69M$ 2.14M$ 1.59M$ 10.08M$ 1.09M
EBIT$ -7.59M$ -10.99M$ -15.91M$ -23.72M$ -29.58M
EBITDA$ -7.41M$ -10.74M$ -15.67M$ -23.49M$ -29.36M
Net Income Common Stockholders$ -7.59M$ -10.99M$ -16.94M$ -1.49M$ -29.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 127.72M$ 111.09M$ 128.17M$ 119.11M$ 103.05M
Total Assets$ 182.39M$ 161.07M$ 174.06M$ 197.41M$ 218.35M
Total Debt$ 0.00$ 0.00$ 0.00$ 426.00K$ 310.00K
Net Debt$ -127.72M$ -111.09M$ -128.17M$ -118.68M$ -102.74M
Total Liabilities$ 52.24M$ 27.25M$ 32.05M$ 40.23M$ 62.02M
Stockholders Equity$ 130.15M$ 133.84M$ 142.01M$ 157.18M$ 156.33M
Cash Flow-
Free Cash Flow$ 22.00M$ -12.31M$ -20.95M$ -7.20M$ -24.64M
Operating Cash Flow$ 22.00M$ -12.32M$ -20.82M$ -6.76M$ -24.56M
Investing Cash Flow$ 2.79M$ -674.00K$ 16.83M$ 7.55M$ 32.53M
Financing Cash Flow$ 22.00K$ -11.00K$ -55.00K$ 49.00K$ -87.00K
Currency in USD

Aclaris Therapeutics Earnings and Revenue History

Aclaris Therapeutics Debt to Assets

Aclaris Therapeutics Cash Flow

Aclaris Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis